POC(Point of Care) 지질 검사 시장 규모, 점유율, 성장 분석 : 제품 유형별, 용도별, 적응증별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Point Of Care Lipid Test Market size was valued at USD 689.68 Million in 2024 and is poised to grow from USD 736.58 Million in 2025 to USD 1246.78 Million by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global point-of-care (POC) lipid test market is evolving around portable analyzers that utilize disposable cartridges to provide rapid cholesterol, triglyceride, and lipoprotein results at various settings, including clinics and pharmacies. Growing cardiovascular disease rates necessitate swift risk assessments that traditional lab processes struggle to meet. Regulatory endorsement of lipid monitoring has propelled market expansion, compelling health systems to adopt portable solutions that lower testing costs and enhance accessibility for underserved populations. Collaborations between pharmacies and POC device manufacturers have demonstrated significant increases in preventive treatment uptake. Moreover, the integration of AI is transforming this landscape by enabling quick interpretation of lipid profiles through smart algorithms, improving accuracy, facilitating real-time alerts for abnormal values, and streamlining workflows to enhance patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Point Of Care Lipid Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Point Of Care Lipid Test Market Segments Analysis

The global point-of-care lipid test market is segmented by product type, application, indication, end user and region. Based on product type, the market is segmented into Instruments and Consumables. Based on application, the market is segmented into Hyperlipidemia, Hypertriglyceridemia, Tangier Disease, Familial Hypercholesterolemia and Others. Based on indication, the market is segmented into Lipid & Lipoprotein Disorders, Atherosclerosis, Liver & Renal Diseases, Diabetes Mellitus and Others. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Clinics and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Point Of Care Lipid Test Market

The increasing prevalence of chronic diseases is driving healthcare providers to seek faster, on-site lipid testing to make timely therapeutic decisions. Point-of-care platforms deliver immediate results without reliance on central laboratories, allowing patients to avoid waiting and enabling clinicians to expedite treatment plans. This rapid response not only enhances patient adherence but also fosters a preventive approach to disease management, regardless of varying clinical resources across different settings. Consequently, the clinical significance of decentralized lipid testing is becoming increasingly apparent, attracting interest from hospitals, primary care clinics, and community health initiatives alike. This growing adoption of point-of-care lipid solutions promotes broader access and improves cardiovascular risk monitoring globally.

Restraints in the Global Point Of Care Lipid Test Market

The advanced components required for accurate lipid testing, such as high-precision sensors and integrated data analytics, often result in a higher cost for these devices. This elevated price point poses a significant challenge for small clinics and facilities operating under strict budget constraints, where financial resources are typically allocated to essential services rather than cutting-edge diagnostic technologies. Consequently, the adoption of these advanced lipid testing solutions remains inconsistent, and limited funding frequently delays their implementation. This hinders overall market growth and restricts the reach of decentralized lipid testing options, particularly in rural areas and underserved communities worldwide.

Market Trends of the Global Point Of Care Lipid Test Market

The Global Point Of Care Lipid Test market is experiencing a significant trend towards digital integration, as healthcare providers increasingly incorporate lipid analyzers into electronic medical records and telehealth platforms. This seamless connectivity facilitates real-time data sharing with clinicians, minimizing diagnostic delays and enhancing personalized treatment approaches while encouraging greater patient engagement. As interoperability standards evolve, device manufacturers are embedding connectivity modules within their instruments, along with secure cloud interfaces, which support collaborative care models across various healthcare settings, including hospitals, primary clinics, and remote monitoring networks. This shift is driving a data-driven approach to cardiovascular risk management, ultimately fostering improved long-term health outcomes and sustainable practices.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Point of Care Lipid Test Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Instruments
  • Single-Parameter Analyzers
  • Multi-Parameter Analyzers
• Consumables
  • Test Strips
  • Cartridges
  • Reagents
  • Calibrators

Global Point of Care Lipid Test Market Size by Application & CAGR (2026-2033)

• Market Overview
• Hyperlipidemia
• Hypertriglyceridemia
• Tangier Disease
• Familial Hypercholesterolemia
• Others

Global Point of Care Lipid Test Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Lipid & Lipoprotein Disorders
• Atherosclerosis
• Liver & Renal Diseases
• Diabetes Mellitus
• Others

Global Point of Care Lipid Test Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Clinics
• Home Care Settings

Global Point of Care Lipid Test Market Size & CAGR (2026-2033)

• North America (Product Type, Application, Indication, End User)
  • US
  • Canada
• Europe (Product Type, Application, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Indication, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (QuidelOrtho)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba ABX SAS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher Scientific International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinocare Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VivaChek Biotech (Hangzhou) Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Callegari Srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiCoBio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cobas (Roche)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orion Diagnostica Oy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cholestech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations